Funding for this research was provided by:
Radius Health, Inc.
Received: 29 August 2019
Accepted: 5 February 2020
First Online: 15 February 2020
Compliance with ethical standards
: EML has received no direct income from potentially conflicting entities. His employer, New Mexico Clinical Research & Osteoporosis Center, has received research grants from Radius, Amgen, Mereo BioPharma, and Bindex; income for service on scientific advisory boards or consulting for Amgen, Radius Health Inc., Alexion Pharmaceuticals, Sandoz, and Samsung Bioepis; service on speakers’ bureaus for Radius Health Inc. and Alexion; project development for University of New Mexico; and royalties from UpToDate for sections on DXA, fracture risk assessment, and prevention of osteoporosis. He is a board member of the National Osteoporosis Foundation, International Society for Clinical Densitometry, and Osteoporosis Foundation of New Mexico. BC and KS are employees of Optum, which received funding from Radius Health, Inc., to conduct the study. SAW, RJW, and YW, are employees of and own equity stock in Radius Health, Inc. LAF is a former employee of, is a current consultant, and owns equity stock in Radius Health Inc. JRC is a consultant for Amgen and Radius Health, Inc., and is an employee of the University of Alabama at Birmingham, which has received research grants from Amgen and Radius Health, Inc.
: All patient data obtained for this analysis were maintained in a de-identified manner and were accessed following protocols compliant with the Health Insurance Portability and Accountability Act (HIPAA).For this type of study, formal consent is not required.